Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Interaction between genes and environment in neurodegenerative diseases.

Elbaz A, Dufouil C, Alpérovitch A.

C R Biol. 2007 Apr;330(4):318-28. Epub 2007 Apr 9. Review.

PMID:
17502288
2.

In search of genes involved in neurodegenerative disorders.

Pardo LM, van Duijn CM.

Mutat Res. 2005 Dec 30;592(1-2):89-101. Epub 2005 Jul 11. Review.

PMID:
16009383
3.

Apolipoprotein E epsilon4 allele in familial and sporadic Parkinson's disease.

Blázquez L, Otaegui D, Sáenz A, Paisán-Ruiz C, Emparanza JI, Ruiz-Martinez J, Moreno F, Martí-Massó JF, López de Munain A.

Neurosci Lett. 2006 Oct 9;406(3):235-9. Epub 2006 Aug 14.

PMID:
16904828
4.

Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases.

Migliore L, Coppedè F.

Mutat Res. 2009 Jul 10;667(1-2):82-97. doi: 10.1016/j.mrfmmm.2008.10.011. Epub 2008 Oct 31. Review.

PMID:
19026668
5.

Genes and the environment in neurodegeneration.

Coppedè F, Mancuso M, Siciliano G, Migliore L, Murri L.

Biosci Rep. 2006 Oct;26(5):341-67. Review.

PMID:
17029001
6.

Genetic interaction between tau and the apolipoprotein E receptor LRP1 Increases Alzheimer's disease risk.

Vázquez-Higuera JL, Mateo I, Sánchez-Juan P, Rodríguez-Rodríguez E, Pozueta A, Infante J, Berciano J, Combarros O.

Dement Geriatr Cogn Disord. 2009;28(2):116-20. doi: 10.1159/000234913. Epub 2009 Aug 13.

7.

The impact of our genes: consequences of the apolipoprotein E polymorphism in Alzheimer disease and multiple sclerosis.

Fazekas F, Enzinger C, Ropele S, Schmidt H, Schmidt R, Strasser-Fuchs S.

J Neurol Sci. 2006 Jun 15;245(1-2):35-9. Epub 2006 Apr 24. Review.

PMID:
16631796
8.

Molecular genetics of Alzheimer's disease: an update.

Brouwers N, Sleegers K, Van Broeckhoven C.

Ann Med. 2008;40(8):562-83. doi: 10.1080/07853890802186905. Review.

PMID:
18608129
9.

Cholesteryl ester transfer protein polymorphism D442G associated with a potential decreased risk for Alzheimer's disease as a modifier for APOE epsilon4 in Chinese.

Chen DW, Yang JF, Tang Z, Dong XM, Feng XL, Yu S, Chan P.

Brain Res. 2008 Jan 2;1187:52-7. Epub 2007 Nov 26.

PMID:
18036514
10.

Risk and protective factors for sporadic Alzheimer's disease.

Stozická Z, Zilka N, Novák M.

Acta Virol. 2007;51(4):205-22. Review.

PMID:
18197729
11.

Association of complement factor H Y402H gene polymorphism with Alzheimer's disease.

Zetterberg M, Landgren S, Andersson ME, Palmér MS, Gustafson DR, Skoog I, Minthon L, Thelle DS, Wallin A, Bogdanovic N, Andreasen N, Blennow K, Zetterberg H.

Am J Med Genet B Neuropsychiatr Genet. 2008 Sep 5;147B(6):720-6. doi: 10.1002/ajmg.b.30668.

PMID:
18163432
12.

Strategies for dissecting genetic-environmental interactions in neurodegenerative disorders.

Schmechel DE, Browndyke J, Ghio A.

Neurotoxicology. 2006 Sep;27(5):637-57. Epub 2006 Jun 3.

PMID:
16870258
13.

Influence of the Pro12Ala polymorphism of PPAR-gamma on age at onset and sRAGE levels in Alzheimer's disease.

Yao L, Li K, Zhang L, Yao S, Piao Z, Song L.

Brain Res. 2009 Sep 29;1291:133-9. doi: 10.1016/j.brainres.2009.07.034. Epub 2009 Jul 23.

PMID:
19631630
14.

The role of vascular factors in late-onset sporadic Alzheimer's disease. Genetic and molecular aspects.

Rocchi A, Orsucci D, Tognoni G, Ceravolo R, Siciliano G.

Curr Alzheimer Res. 2009 Jun;6(3):224-37. Review.

PMID:
19519304
15.

Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease.

Yu JT, Tan L, Song JH, Sun YP, Chen W, Miao D, Tian Y.

Brain Res. 2009 Feb 9;1253:169-75. doi: 10.1016/j.brainres.2008.11.083. Epub 2008 Dec 3.

PMID:
19073159
16.

Genetics of Alzheimer's disease. A rapidly evolving field.

Serretti A, Olgiati P, De Ronchi D.

J Alzheimers Dis. 2007 Aug;12(1):73-92. Review.

PMID:
17851196
17.

[Vascular risk factors and Alzheimer disease risk: epidemiological studies review].

Cowppli-Bony P, Dartigues JF, Orgogozo JM.

Psychol Neuropsychiatr Vieil. 2006 Mar;4(1):47-60. Review. French.

18.

Epigenetics in neurodegeneration: a new layer of complexity.

Marques SC, Oliveira CR, Pereira CM, Outeiro TF.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):348-55. doi: 10.1016/j.pnpbp.2010.08.008. Epub 2010 Aug 22. Review.

PMID:
20736041
19.

Polymorphisms of APOE and LRP genes in Brazilian individuals with Alzheimer disease.

Bahia VS, Kok F, Marie SN, Shinjo SO, Caramelli P, Nitrini R.

Alzheimer Dis Assoc Disord. 2008 Jan-Mar;22(1):61-5. doi: 10.1097/WAD.0b013e31815a9da7.

PMID:
18317248
20.

Important differences between human and mouse APOE gene promoters: limitation of mouse APOE model in studying Alzheimer's disease.

Maloney B, Ge YW, Alley GM, Lahiri DK.

J Neurochem. 2007 Nov;103(3):1237-57. Epub 2007 Sep 8.

Supplemental Content

Support Center